BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36481756)

  • 1. Pan-cancer analysis of the prognostic and immunological role of PAQR4.
    Wang K; Meng J; Wang X; Yan M; Liu S; Yang S; Xu S; Liu D; Li C; Yang K
    Sci Rep; 2022 Dec; 12(1):21268. PubMed ID: 36481756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High PAQR4 mRNA Expression May Play a Key Role in Prognosis of Kidney Renal Papillary Cell Carcinoma.
    Liu C; Cai W; Tang P; Li C
    Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4.
    Yang Z; Zhu Y; Li Z; Pu Z; Lin Y; Deng Y; Li N; Peng F
    Comput Math Methods Med; 2022; 2022():2528164. PubMed ID: 36573110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
    Wu Y; Lin Z; Tang X; Tong Z; Ji Y; Xu Y; Zhou Z; Yang J; Li Z; Liu T
    Front Immunol; 2023; 14():1182030. PubMed ID: 37388742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma.
    Qu C; Ma T; Yan X; Li X; Li Y
    Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance.
    Chen W; Li X; Jiang Y; Ni D; Yang L; Wu J; Gao M; Wang J; Song J; Shi W
    Sci Rep; 2023 Nov; 13(1):19209. PubMed ID: 37932473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation.
    Xu P; Jiang L; Yang Y; Wu M; Liu B; Shi Y; Shen Q; Jiang X; He Y; Cheng D; Xiong Q; Yang Z; Duan L; Lin J; Zhao S; Shi P; Yang C; Chen Y
    Theranostics; 2020; 10(8):3767-3778. PubMed ID: 32206121
    [No Abstract]   [Full Text] [Related]  

  • 10. PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis.
    Zhao Q; Zhang Z; Wu Y
    Ann Clin Lab Sci; 2022 Mar; 52(2):185-195. PubMed ID: 35414497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive pan-cancer analysis of CDH5 in immunological response.
    Li Y; Wu Q; Lv J; Gu J
    Front Immunol; 2023; 14():1239875. PubMed ID: 37809080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4.
    Feng Y; Sun T; Yu Y; Gao Y; Wang X; Chen Z
    J Pharmacol Sci; 2018 Oct; 138(2):96-106. PubMed ID: 30322804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
    Li H; Zhang Y; Zheng S
    Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

  • 17. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
    Shi K; Zhou J; Li M; Yan W; Zhang J; Zhang X; Jiang L
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166965. PubMed ID: 38000776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted gene co-expression network analysis reveals prognostic and diagnostic significance of
    Feng T; Lai C; Zhong D; Luo L; Zou H; Wang G; Yang Q; Yao Y; Huang X
    J Gastrointest Oncol; 2022 Apr; 13(2):768-779. PubMed ID: 35557577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.